Closing Gaps in STI Care Through Molecular Point-of-Care Testing

Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include:CDC and US Preventive Services Task Force STI screening recommendationsWhether or not laboratory-based STI tests contribute to increasing antibiotic resistanceRole of point-of-care testing and strategies for implementationPresenter:Jeffrey D. Klausner, MD, MPHClinical Professor of MedicinePopulation and Public Health Sciences LeadInfectious Diseases Epidemiology and Applies Studies (I.D.E.A.S.) InitiativeKeck School of Medicine of the University of Southern CaliforniaLos Angeles, CaliforniaLink to full program:https://bit.ly/4nS7rYEGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are no comments yet.

Please log in to write the first comment.